LoginSign Up
Inscripta

Inscripta

A gene editing technology company founded in 2015 and based in Boulder, CO, USA.

Inscripta, founded in 2015 by Andrew Garst, Ryan T Gill and Tanya Lipscomb, provides gene editing tools for academic and commercial customers.In 2018 Inscripta acquired Solana Biosciences, a life sciences company founded by veterans of IlluminaTM . Expansion plans include a new office in the life sciences hub of San Diego.

Inscripta has an enzyme engineering program rather than a particular application and they aim to provide tools for their customers to create their own applications faster.To tackle the lack of access and high cost of CRISPR gene-editing enzymes Inscripta is engineering CRISPR endonucleases called MADzymes.The DNA sequence for one MADzyme, MAD7 is provided free for any R&D use without reach-through royalty rights.MAD7 is derived from the genome of Eubacterium rectale and is a codon-optimized nuclease similar to Cpf1 (Cas12a). Inscripta is also engineering novel enzymes for exclusive use by industry partners.

Timeline

People

Name
Role
Related Golden topics

Don Masquelier

VP Engineering

Erik Warnecke

VP Finance

Kevin Ness

CEO

Michael Graige

Chief Technical Officer

Further reading

Title
Author
Link
Type

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References